FDA Clearance Tracker · P230044
alfapump System
Last checked: Nov 19, 2026Latest source record: Dec 20, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Dec 20, 2024
Approved
Time to decision
358 days
Received Dec 28, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P230044
- Device name
- alfapump System
- Applicant
- Sequana Medical NV
- Applicant location
- Sint-Denijs-Westrem
- Received
- Dec 28, 2023
- Decided
- Dec 20, 2024
- Decision
- Approved
- Supplements
- 5 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- alfapump System (SDQ)
- Device class
- Class III
- Specialty
- GI, Urology & Nephrology
FDA's approval statement
As written in FDA's record.
Approval for alfapump System for the indication of: The alfapump System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of excess peritoneal fluid from the peritoneal cavity into the bladder, where it can be eliminated through normal urination.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code SDQ (alfapump System).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for Sequana Medical NV
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.